Skip to main content

Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Lee, Beverly beverly.lee@nih.gov	5E532	Program Officer \| Community Oncology and Prevention Trials
	Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152	5E516	Nurse Consultant \| Community Oncology and Prevention Trials
	Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081	5E434	Program Specialist \| Community Oncology and Prevention Trials
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533	5E448	Program Officer \| Community Oncology and Prevention Trials
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Voss, Alyssa, M.P.H. alyssa.voss@nih.gov 240-204-3107		Writer/Editor \| Office of the Director Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials

Grants

PI Name	PI Organization	Title	Grant Number Sort descending	Program Official
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Acharya, Munjal M	University Of California-Irvine United States	Stem cell-derived exosomes to ameliorate chemobrain	5R01CA262213-03	Rachel Altshuler, Ph.D.
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-05	Rachel Altshuler, Ph.D.
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-04	Rachel Altshuler, Ph.D.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Rini, Christine	Northwestern University At Chicago United States	Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial	5R01CA271220-04	Brennan Streck, Ph.D., RN, M.P.H.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	Rachel Altshuler, Ph.D.
Cohen, Lorenzo	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery	5R01CA272565-03	Brennan Streck, Ph.D., RN, M.P.H.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03	Rachel Altshuler, Ph.D.
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-04	Rachel Altshuler, Ph.D.
Mclouth, Laurie	University Of Kentucky United States	Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment	5R01CA283929-03	Brennan Streck, Ph.D., RN, M.P.H.
Bryan, Angela	University Of Colorado United States	Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC	5R01CA284860-03	Brennan Streck, Ph.D., RN, M.P.H.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-03	John Clifford, Ph.D.
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	5R21CA273832-02	Brennan Streck, Ph.D., RN, M.P.H.
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	5R21CA280230-02	Eileen Dimond, R.N., M.S.